Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lung Cancer Symptom Assessment and Management Intervention

This study has been completed.
Boston Medical Center
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Mary E. Cooley, Phd, Dana-Farber Cancer Institute Identifier:
First received: February 26, 2009
Last updated: October 19, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)